EMVERM (Amedra Pharmaceuticals LLC)
Welcome to the PulseAid listing for the EMVERM drug offered from Amedra Pharmaceuticals LLC. This Antihelminthic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amedra Pharmaceuticals LLC |
| NON-PROPRIETARY NAME: | mebendazole |
| SUBSTANCE NAME: | MEBENDAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antihelminthic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, CHEWABLE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-02-15 |
| END MARKETING DATE: | 2018-11-30 |
EMVERM HUMAN PRESCRIPTION DRUG Details:
| Item Description | EMVERM from Amedra Pharmaceuticals LLC |
| LABELER NAME: | Amedra Pharmaceuticals LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2016-02-15 |
| END MARKETING DATE: | 2018-11-30 |
| PRODUCT ID: | 52054-107_1f128e35-5f96-45c1-ac0a-cf04ba9161c6 |
| PRODUCT NDC: | 52054-107 |
| APPLICATION NUMBER: | ANDA073580 |
Other MEBENDAZOLE Pharmaceutical Manufacturers / Labelers:
